SHMT2 and metastatic malignant neoplasm: Notably, while the inhibition of both the cytosolic and mitochondrial SHMT isoforms was effective for both primary and metastatic cancer cell lines, targeting only cytosolic activities by inhibition of DHFR or MTHFD1, inhibited proliferation selectively in the metastatic cell lines.